Gouri Sreepati, MD
Gastroenterology · Estero, FLNPI 1972891000
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 34.0% of the total. Reporting peaked in 2022 at $1,163 and has fallen 95.4% since, to $53 in 2025. That places this record below the midpoint for gastroenterology clinicians in FL, where the typical reported total is $3,025.
Across 153 payments — averaging $18.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$956
- Johnson & Johnson$486
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$400
- Takeda Pharmaceuticals U.S.A., Inc.$187
- Daiichi Sankyo Inc.$163
- Pfizer$123
- plus $500 from 13 others
What the payments were for
- Food & beverage$2,68395%
- Education$1325%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $956 |
| Johnson & Johnson | 23 | $486 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $400 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $187 |
| Daiichi Sankyo Inc. | 10 | $163 |
| Pfizer | 8 | $123 |
| Bristol Myers Squibb | 5 | $97 |
| Redhill Biopharma Inc. | 4 | $63 |
| Merck | 4 | $58 |
| Ironwood Pharmaceuticals, Inc | 3 | $49 |
| Sanofi | 2 | $39 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Vivus LLC | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $33 |
| Gilead | 2 | $28 |
| Boston Scientific | 1 | $21 |
| AstraZeneca | 1 | $18 |
| UCB, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
How this compares
$2,815 in reported general payments places this provider in the 45th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 109 | $17,694 |
| Mesalamine | 11 | $5,337 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 22 | $1,370 |
| Pantoprazole Sodium | 112 | $1,130 |
| Lactulose | 13 | $262 |
| Omeprazole | 21 | $252 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Estero
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
- Joanna LopezMiami$670K
- Jose NietoSebring$573K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.